Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing-Reference-Cited by-同舟云学术

Muscle mass affects paclitaxel systemic exposure and may inform personalized paclitaxel dosing

Published:2022-02-14 Issue:7 Volume:88 Page:3222-3229
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit J Clinical Pharma

Author:

Hertz Daniel L.¹^ORCID,Chen Li¹,Henry N. Lynn²^ORCID,Griggs Jennifer J.²,Hayes Daniel F.²^ORCID,Derstine Brian A.³,Su Grace L.³,Wang Stewart C.³^ORCID,Pai Manjunath P.¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy University of Michigan College of Pharmacy Ann Arbor MI USA

2. Department of Internal Medicine, Division of Hematology/Oncology University of Michigan Medical School Ann Arbor MI USA

3. Morphomic Analysis Group University of Michigan Medical School Ann Arbor MI USA

Funder

National Cancer Institute

National Center for Advancing Translational Sciences

Agency for Healthcare Research and Quality

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15244

Reference41 articles.

1. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update

2. SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer

3. Randomized Phase III Trial of Weekly Compared With Every-3-Weeks Paclitaxel for Metastatic Breast Cancer, With Trastuzumab for all HER-2 Overexpressors and Random Assignment to Trastuzumab or Not in HER-2 Nonoverexpressors: Final Results of Cancer and Leukemia Group B Protocol 9840

4. Neurotoxicity of taxol;Rowinsky EK;J National Cancer Inst Monogr,1993

5. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A signal-on electrochemiluminescence (ECL) sensor based on luminol@carbon nanotubes and CdTe-ZnS@hydroxyapatite for the detection of paclitaxel;Microchemical Journal;2024-09

2. Using maximum plasma concentration (Cmax) to personalize taxane treatment and reduce toxicity;Cancer Chemotherapy and Pharmacology;2024-05-11

3. The Emerging Role and Clinical Applications of Morphomics in Diagnostic Imaging;Canadian Association of Radiologists Journal;2024-04-16

4. Evolution of predictive risk factor analysis for chemotherapy-related toxicity;Supportive Care in Cancer;2023-09-29

5. Genetic variations that influence paclitaxel pharmacokinetics and intracellular effects that may contribute to chemotherapy-induced neuropathy: A narrative review;Frontiers in Pain Research;2023-05-12